SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Act of 1934
Date of Report (Date of earliest event reported): April 23, 2012
FONAR CORPORATION
______________________________________________________
(Exact name of registrant as specified in its charter)
Delaware | 0-10248 | 11-2464137 | ||
(State or other jurisdiction of incorporation)
|
(Commission File Number) |
(I.R.S. Employer Identification Number)
|
110 Marcus Drive
Melville, New York 11747
(631) 694-2929
__________________________________________
(Address, including zip code, and telephone number
of registrant's principal executive office)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 3.01(a) Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On April 23, 2012, FONAR Corporation ("FONAR") received a letter from The NASDAQ Stock Market LLC ("NASDAQ") indicating that the Company had failed to remain in compliance with NASDAQ Listing Rule 5605(c)(2)(A) (the “Rule”), the audit committee composition requirement, as a result of the death of Mr. Robert Djerejian on August 21, 2011.
Mr. Djerejian was an independent director who also served as a member of the audit committee. The continued listing rules require that the audit committee be comprised of at least three directors, each of whom must be independent, and that the majority of the board be comprised of independent directors.
FONAR has advised the Staff that the board of directors has appointed Mr. Ronald G. Lehman to fill the vacancies on the board and the audit committee, thereby bringing FONAR back into compliance with the Rule.
Mr. Lehman is a Managing Director of Investment Banking with Bruderman Brothers, Inc., a private, New York-based broker-dealer (a FINRA member firm). Mr. Lehman directly manages all facets of the firm’s transaction processes, from deal origination, to sourcing capital, to negotiating deal structures, through documentation and closing. The firm provides buy and sell-side advisory, capital raising, and consulting services to lower middle-market companies. Mr. Lehman specializes in advising healthcare services companies and has recently completed the recapitalizations of Professional Orthopedic and Sports Medicine, P.C. and Dynamic Healthcare Services, Inc., among others.
From 2000 to 2008, Mr. Lehman worked for various Bruderman entities as a buy and sell-side advisor, and acted as a principal in several private equity transactions. In 2008, he joined Health Diagnostics, LLC, one of the country’s fastest growing diagnostic imaging providers, as a Senior Vice President of Acquisitions where he managed the company’s acquisition and corporate finance activities. Mr. Lehman returned to Bruderman Brothers in 2010 to lead the firm’s investment banking efforts. He also participates in the firm’s merchant banking investments and oversees many of these assignments.
From 1998 to 2000, Mr. Lehman worked at Deutsche Bank Securities, Inc. and last held the position of Associate in their Global Custody Group. Mr. Lehman graduated from Columbia University with a B.A. in 1998.
A copy of the Company's press release announcing receipt of the Staff’s letter is attached hereto as Exhibit 99 and is incorporated herein by reference.
Exhibits
99. Press Release dated April 27, 2012
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
FONAR CORPORATION
(Registrant)
By: /s/ Raymond Damadian
Raymond Damadian
President and Chairman
Dated: April 27, 2012
Exhibit 99
NEWS For Immediate release Contact: Daniel Culver Director of Communications www.fonar.com Email: investor@fonar.com |
FONAR Corporation The Inventor of MR Scanning™ An ISO 9001 Company Melville, NY 11747 Phone: 631-694-2929 Fax: 631-390-1709
|
FONAR BOARD OF DIRECTORS APPOINTS INDEPENDENT DIRECTOR
MELVILLE, NEW YORK, April 27, 2012 – FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning™, today announced that on Thursday, April 26, 2012, its board of directors had appointed Ronald G. Lehman as a replacement independent director to fill vacancies on the Company’s board of directors and audit committee. FONAR shareholders will have an opportunity to confirm the appointment at the annual shareholder meeting scheduled for June 25, 2012.
Raymond Damadian, M.D., president and chairman of the board, said, “Mr. Lehman is a talented individual with strengths advising healthcare services companies and with significant corporate finance experience. We expect him to be very beneficial to our growth. We are delighted to have him working with the board of directors and as a member of the audit committee.”
Dr. Damadian continued, “All this follows the sad passing of our good friend Robert Djerejian, who was an able member of the board of directors since 2002.”
Mr. Lehman is a Managing Director of Investment Banking with Bruderman Brothers, Inc., a private, New York-based broker-dealer (a FINRA member firm). Mr. Lehman directly manages all facets of the firm’s transaction processes, from deal origination, to sourcing capital, to negotiating deal structures, through documentation and closing. The firm provides buy and sell-side advisory, capital raising, and consulting services to lower middle-market companies. Mr. Lehman specializes in advising healthcare services companies and has recently completed the recapitalizations of Professional Orthopedic and Sports Medicine, P.C. and Dynamic Healthcare Services, Inc., among others.
From 2000 to 2008, Mr. Lehman worked for various Bruderman entities as a buy and sell-side advisor, and acted as a principal in several private equity transactions. In 2008, he joined Health Diagnostics, LLC, one of the country’s fastest growing diagnostic imaging providers, as a Senior Vice President of Acquisitions where he managed the company’s acquisition and corporate finance activities. Mr. Lehman returned to Bruderman Brothers in 2010 to lead the firm’s investment banking efforts. He also participates in the firm’s merchant banking investments and oversees many of these assignments.
From 1998 to 2000 Mr. Lehman worked at Deutsche Bank Securities, Inc. and last held the position of Associate in their Global Custody Group. Mr. Lehman graduated from Columbia University with a B.A. in 1998.
Page 1 of 2
FONAR Corporation | Page 2 of 2 |
On Monday, April 23, 2012, The NASDAQ Stock Market LLC ("NASDAQ") staff sent a letter to FONAR stating that FONAR was not in compliance with NASDAQ’s audit committee composition requirement as set forth in Listing Rule 5605 (c)(2)(A), due to Mr. Djerejian’s death on August 21, 2011. Following the appointment of Mr. Lehman, FONAR has regained compliance with the NASDAQ audit committee composition requirement.
About FONAR
FONAR (NASDAQ:FONR), Melville, NY, The Inventor of MR Scanning™, was incorporated in 1978, and is the first, oldest and most experienced MRI company in the industry. FONAR introduced the world’s first commercial MRI in 1980, and went public in 1981. Since its inception, nearly 300 recumbent-OPEN MRIs and 150 UPRIGHT® Multi-Position™ MRI scanners have been installed worldwide. FONAR’s stellar product is the UPRIGHT® MRI (also known as the Stand-Up® MRI), the only whole-body MRI that performs Position™ imaging (pMRI™) and scans patients in numerous weight-bearing positions, i.e. standing, sitting, in flexion and extension, as well as the conventional lie-down position. The FONAR UPRIGHT® MRI often sees the patient’s problem that other scanners cannot because they are lie-down only. The patient-friendly UPRIGHT® MRI has a near-zero claustrophobic rejection rate by patients. As a FONAR customer states, “If the patient is claustrophobic in this scanner, they’ll be claustrophobic in my parking lot.” Approximately 85% of patients are scanned sitting while they watch a 42” flat screen TV. FONAR is headquartered on Long Island, New York.
#
UPRIGHT® and STAND-UP® are registered trademarks and The Inventor of MR Scanning™, Full Range of Motion™, Multi-Position™, Upright Radiology™, The Proof is in the Picture™, True Flow™, pMRI™, Spondylography™, Dynamic™, Spondylometry™, CSP™, and Landscape™, are trademarks of FONAR Corporation.
This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company's financial results may be found in the company's filings with the Securities and Exchange Commission.
###